The summary below was generated by an AI language model and may contain errors or omissions. All other content on this page is deterministically extracted from the original SEC EDGAR filing.
Medtronic added two new risk disclosures in 2023 addressing ESG practices and financial sector instability, while maintaining all previously disclosed risks without removal. The company substantively modified five existing risk factors, including those related to healthcare policy, tax liabilities, debt obligations, and business integration challenges, reflecting evolving concerns in regulatory, financial, and operational areas.
Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.
🟢 New in Current Filing
We are subject to risks related to our environmental, social and governance (ESG) practices and initiatives.
🔒
🟢 New in Current Filing
Instability in the financial sector could adversely affect our revenues, results of operation, or financial condition.
🔒
🟡 Modified
Healthcare policy changes may have a material adverse effect on us.
🔒
🟡 Modified
Changes in tax laws or exposure to additional income tax liabilities could have a material impact on our business, results of operations, financial condition and cash flows.
🔒
🟡 Modified
We have debt obligations that create risk.
🔒
🟡 Modified
Failure to integrate acquired businesses into our operations successfully, or challenges related to the Company's strategic initiatives, including divestitures, as well as liabilities or claims relating to such acquired businesses or divestitures, could adversely affect our business.
🔒
🟡 Modified
Public health crises have had, and may continue to have, an adverse effect on certain aspects of our business, results of operations, financial condition, and cash flows. The nature and extent of future impacts are highly uncertain and unpredictable.
🔒